How can #GenomeEngineering improve health? I'm excited to discuss this with Trevor Martin and Janice Nevin of ChristianaCare at #HLTH2019. If you're there, join us Sunday at 4pm. Message me if you want to meet up.

We're not only creating the tools to enable a biotech revolution, we're taking an active role in shaping the US #bioeconomy. Jason T Gammack & Kevin Ness went to Washington to lobby legislators and attend a White House summit. #BioeconomyAlliance ow.ly/mvZr50wU69z

"We’re in the midst of a historical revolution, a biological revolution. This is the century of biology. We’re going to gain mastery over life & it will have implications over everything we do." John Stuelpnagel chats w/ @theraltweet on mendelspod bit.ly/2NIYRff

How to do things write: Make digital genome engineering scalable, simple & accessible to even small research labs, using open source nucleases. Hear what Nathan Pearson thinks of our new #onyx platform on this recent mendelspod podcast. ow.ly/XMR850x3oeL

Today we're announcing our acquisition of $125M in Series D Financing. The overwhelming interest we received w/ the recent launch of our Onyx platform, along w/ this significant funding, is tremendous validation of our novel approach to genome engineering. ow.ly/LKUb50xwdlp

Serial biotech entrepreneur Kevin Ness has raised $260M to get his genome-engineering device into the hands of every scientist who wants one via @forbes @forbestech forbes.com/sites/amyfeldm…

Thanks, Jef! RT Jef Boeke: Amazing work Kevin. Cant wait to get our hands on the amazing Onyx box!!! x.com/amyfeldman/sta…

While last year our most popular articles dealt with #fundraising and #investing, #syntheticbiology in space, and education, this year’s most popular themes included #CRISPR, academic research, real-world applications, and new platforms. bit.ly/2qXgAIt #synbio

19December: How does Inscripta, Inc. plan to use the proceeds of the $125M in financing it recent raised? My latest for Genetic Engineering & Biotechnology News: ow.ly/tKyI50xDPRU

One of the most integrated life science tool platforms that has ever been created? And not just a new tool to do science-an entirely new approach to gene editing, says Kevin Ness in GenomeWeb feature on the #Onyx Digital Genome Engineering Platform ow.ly/TTbb50xQjZL

"We can hardly imagine, much less prognosticate, how this will impact our understanding of biology." John Stuelpnagel & Bryan Roberts discuss how tools like the #Onyx Digital Genome Engineering platform are revolutionizing #genomics in FORTUNE ow.ly/sfDX50xVdhD

While transformative, first gen #CRISPR tech is limited in terms of editing efficiency, scalability, types of modifications available & ease of use. Find out about the next generation, push-button #geneediting tool, #Onyx, in this @LabRoots webinar. ow.ly/lvUQ50yljT0

We're feeling fierce today! We've been named by Fierce Medtech as one of the most promising private medtech companies in the industry. Thanks for adding us to 2019’s class of Fierce 15! fiercebiotech.com/special-report…

On #TBT, we're flashing back to the launch of our #Onyx Digital Genome Engineering platform at #SynBioBeta2019. It was a great day, starting with Kevin Ness's keynote talk. #geneediting #CRISPR ow.ly/QeRr50yA9jC

Top Techie Kevin Ness is building new tools for biologists: ow.ly/cZvn50zr4HA Inscripta, Inc.

Thanks, Luke Timmerman, for the opportunity to share my personal and professional life story, my work at Inscripta, Inc., and the future of #genomeengineering. You can listen to our conversation on the #LongRun podcast. ow.ly/AbIB50As22J

Inscripta is providing "some pretty profound improvements to the toolset that biologists are going to have," Kevin Ness tells Luke Timmerman in #TheLongRun podcast. Hear how the #Onyx digital #genomeengineering platform could transform #biology. ow.ly/mZyq50AwS8I

Thanks, Jim! x.com/JTananbaum/sta…

"We have never had a technology w/ the potential of what biology can do to solve some of the largest problems facing us. However, that is going to stay a potential unless we harness it by building better tools." Kevin Ness describes his solution. ow.ly/D2ZB50AwSeL

Our technology & products allow for digital #genomeengineering on an unprecedented scale. We are committed to ensuring this is done in a safe, responsible & ethical way. Learn more about the steps we are taking to ensure #biosecurity. ow.ly/AC0A50BKKzT